{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-075860","form_type":"8-K","ticker":"CC","cik":"0001627223","company_name":"Chemours Co","filed_at":"2024-03-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.857869+00:00","generated_at":"2026-06-04T08:29:48.918584+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Chemours appoints Denise Dignam as President and CEO, replacing Mark Newman","bullets":["Denise Dignam named President and CEO effective March 22, 2024; she was interim CEO since February 2024.","Mark Newman resigned as officer and director; separation agreement grants extended stock option exercise period but no severance.","Dignam's compensation: $975k base salary, 120% target bonus, $4.355M LTI award.","Matthew Abbott continues as interim CFO; search for permanent CFO underway.","Diane Iuliano Picho named interim President, Titanium Technologies."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-075860","json":"https://secwatch.observer/filing/0001193125-24-075860.json","markdown":"https://secwatch.observer/filing/0001193125-24-075860.md","text":"https://secwatch.observer/filing/0001193125-24-075860.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1627223/000119312524075860/0001193125-24-075860-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1627223/000119312524075860/d814363d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T08:29:48.918584+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3c73b8f14d","claim":"Mark Newman resigned as President and Chief Executive Officer at Chemours Co.","evidence_excerpt":"Mark Newman, who resigned from his officer and director positions with the Company, also effective as of March 22, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1627223/000119312524075860/0001193125-24-075860-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"dae433a1e1","claim":"Denise Dignam was named as President and Chief Executive Officer at Chemours Co.","evidence_excerpt":"The Board of Directors (the “Board”) of The Chemours Company (the “Company”) has named Denise Dignam, formerly Interim Chief Executive Officer, as President and Chief Executive Officer and as a member of the Board, effective as of March 22, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1627223/000119312524075860/0001193125-24-075860-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"named"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}